Navigation Links
Merck to pay $ 253.5 million to Vioxx victim family

On Friday, a Texas jury found Merck liable for the death of Robert C. Ernst, who died in May 2001 after taking Vioxx, a pain killer made by the company. After two days of deliberations, the jury said that Carol Ernst, Mr. Ernst’s widow, // should be awarded $ 253.5 million.

Over 5 years, about 20 million people worldwide took Vioxx before Merck stopped selling the drug in September 2004, after a clinical trial found irrefutable evidence that Vioxx had heart risks compared with a placebo.

Mrs. Ernst’s lawyers said that Merck was long aware of Vioxx’s potential heart risks but hid those risks from patients. Merck’s stock price fell almost 8%, although Texas rules on punitive damages will automatically lower the verdict to $26.1 million and Merck has already said it plans to appeal the case.

Texas case means for the thousand of additional Vioxx suits that Merck will face. The answer could determine whether Merck will survive as a strong, independent company or will be crippled for years or even decades. The Texas case was the first Vioxx lawsuit o reach trial, but 4,200 other suits have already been filed, and many are approaching juries.

Friday’s verdict in Texas was a disappointment to all of us at Merck because we know we acted responsibly “Merck’s general counsel, Kenneth C Frazier said in a statement.

It was found that scientists at Merck were worried about Vioxx’s potential cardiovascular risks as early as 1997, two years before Merck began selling the drug. Dr. Alise Reicin, a Merck scientist wrote in a 1997 email message: “C.V. events’ is scientific shorthand for cardiovascular problems like strokes or heart attacks. Dr. Jerry Avorn, Professor at Harvard Medical School said he was not surprised that he jury responded as vehemently as it did. br>

'"/>




Page: 1

Related medicine news :

1. E Merck introduces Livogen Z with zinc sulphate
2. Merck and Takeda to collaborate in the sale of Cancer drug Matuzumab
3. Judgment In Favor Of Merck For Vioxx Drug
4. Merck, ICMR to conduct joint trials on cervical cancer vaccine
5. Merck in the Dock Due To Vioxx
6. Merck Says Januvia Effective In Type 2 Diabetes
7. Dr Reddys Launches Generic Version Of Mercks Proscar Tablets
8. Patency On Two Drugs From Merck & Pfizer’s To Expire Soo
9. Developing Nations to Get Gardasil at Lesser Rates from Merck Soon
10. Acid Test - Glaxos Cervarix, and Mercks Gardasil, Compete
11. Ranbaxy in Fray to Buy Mercks Generic Drugs Unit

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Merck pay million Vioxx victim family

(Date:11/24/2009)... The molecular cause of inflammatory bowel d...esented at the upcoming 2009 Advances in Inflammat...s Foundation’s Clinical & Research Confe...y identify a causative mutation for Crohn’s ...Vocus) November 24, 2009 -- The molecular cause of...
(Date:11/24/2009)...s,Nov.24/PRNewswire/--NIP,Inc.todayannouncedtheacq...tion,sleadingexecutivecompensationandbenefitplanpr...ionalofficesinLosAngeles,Milwaukee,Boston,Chicagoa...enownedexpertintheexecutivebenefitsindustry. ,,...readyhassignificantmarketpresence,"statesBillPollo...
(Date:11/24/2009)...NO,Calif.,Nov.24/PRNewswire/--Nextmonth,UnitedHeal...edathelpingHispanic-Americanseniorsunderstandtheba...ragedtotakeafreeZumba®Goldclass,aLatin-infuse...a,cumbia,rumba,andtango. ,, UnitedHealthcarewil...ortableandengagedwhenlearningabouttheirhealthcareo...
(Date:11/24/2009)...Nov.24/PRNewswire/--TheUnionLaborLifeInsuranceComp...dwithVSP(®),()thenation,slargestvisionbenefit...ceproductstounions,uniontrustfunds,unionemployersa...tsofferingservicesincludingcomprehensiveeyeexams,b...howimportantqualityeyecareis,"statedBruceSmith,Nat...
(Date:11/24/2009)...lement may help ward off peripheral artery diseas...(HealthDay News) -- Among people aged 75 and older...vent heart attacks, stroke or death, a new study f... herbal remedy might help prevent the leg-circulat...wever. , Ginkgo contains nutrients called flavo...
Breaking Medicine News(10 mins):Health News:Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research 2Health News:Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research 3Health News:Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research 4Health News:NIP Acquires San Diego Executive Benefits Firm 2Health News:UnitedHealthcare To Offer Seniors Hispanic-Centered Medicare Education Seminars Combined With a Latin-Themed Fitness Program 2Health News:Union Labor Life & VSP Vision Care Align to Offer Vision Insurance Products 2Health News:Ginkgo Won't Prevent Heart Attack, Stroke in Elderly 2Health News:Ginkgo Won't Prevent Heart Attack, Stroke in Elderly 3
...ws Great for Moms and Babies, Bad for Mercury Fear...,seafood consumption guidelines for pregnant women...ers, Healthy Babies Coalition (HMHB), David,Martos...y swung back in the,direction of common sense. For...
...d Center for Geriatric Nursing Excellence in the U...r Hartford centers in the nation, have been funded... nurses have the most recent evidence-based guidel...ic Nursing Collaborative, are in the UI College of...
....J., Oct. 4 Understanding and Treating,Depression...ion produced by,the Multiple Sclerosis Association...ce on depression for both patients and families af...h topics as,the hidden symptoms of depression; war...
...7 National IPF Awareness Week on Capitol Hill Driv...dly Lung Disease, SAN JOSE, Calif., Oct. 4 The C...ced that the success of its fifth,annual National ...fibrosis (IPF), a progressive and ultimately fatal...
...on, wellness, and incentive system meets crucial n...et, FRANKLIN, Tenn., Oct. 4 Fontis Healthcare Se...d incentive support platform for,Group Health Savi...se of HSAs for employers, employees, and insurance...
...., Oct. 4 The following is a,statement regarding ...eople,store their health information online:, It ...le and other IT,leaders plan to develop personal h...Having ready access to your own,health information...
Other Medicine News:Health News:Consumer Group Statement on Seafood and Health: 'We Told You So' 2Health News:Multiple Sclerosis Association of America Publishes Booklet about Depression in Multiple Sclerosis 2Health News:CPF Urges Congress to Increase Funding for IPF Research in 2009 Federal Budget 2Health News:CPF Urges Congress to Increase Funding for IPF Research in 2009 Federal Budget 3Health News:CPF Urges Congress to Increase Funding for IPF Research in 2009 Federal Budget 4Health News:Fontis Health Launches Online HSA Support System 2Health News:Statement Regarding Microsoft's Announcement of New Services to Help People Store Their Health Information Online 2
(Date:11/24/2009)..., MISSISSAUGA,Ontario,Nov.24/PRNewswire-FirstCall/...adeveloperoftechnologyandproductstargetingtheimmun...kChimieS.A.S.("MerckChimie")isprogressingtothenext...arysilvercoatedparamagneticBeads("Beads"). ,, P...rthisyear,CardioGenicssuppliedMerckChimiewithitspr...
(Date:11/24/2009)..., FRANKLIN,Mass.,Nov.24/PRNewswire-FirstCall/--Ech...developingitsneedle-freeSymphony(TM)tCGMSystemasan...onitoring(tCGM)systemanditsPrelude(TM)SkinPrepSyst...rickT.Mooney,M.D.,ChairmanandChiefExecutiveOfficer...maceuticalsConference,sponsoredbytheNewYorkSociety...
(Date:11/24/2009)..., NORTHHOLLYWOOD,Calif.,Nov.24/PRNewswire-FirstCal...leadingnationalhospitalistphysiciangrouppracticeco...IPChospitalist,wasnamedby ACPHospitalist asoneofth...intheNovember2009issueofthemagazine. ,, Dr.Vaid...dcurrentlyservesasdirectorofhospitalmedicineatSt.M...
Breaking Medicine Technology:CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 2CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 3Echo Therapeutics to Present at the New York Society of Security Analysts' 13th Annual Biotech and Specialty Pharmaceuticals Conference 2IPC The Hospitalist Company's Philip Vaidyan, M.D. Named a Top Hospitalist of 2009 2Cell Biosciences Completes Acquisition of Alpha Innotech 5802 1Anadys Pharmaceuticals to Present at the Oppenheimer Healthcare Conference 5797 1Anadys Pharmaceuticals to Present at the Oppenheimer Healthcare Conference 5797 2Gene Variants Behind Vulnerability to Yeast Infections 60280 1Gene Variants Behind Vulnerability to Yeast Infections 60280 2Gene Variants Behind Vulnerability to Yeast Infections 60280 3
...ng CIMZIA,s long-term benefits and value in,modera... American College,of Gastroenterology (ACG), ORLA...this week by UCB at the American College of Gastro...IMZIA(R) (certolizumab pegol) - the,only PEGylated...ovides,sustained improvement in symptoms with stab...
... 7 , - 125 Patient, Prospective Randomized Placeb...gnificant Improved Overall Survival, Bavarian Nor...m the,therapeutic prostate cancer vaccine candidat...he recently entered partnership with the National,...om the Phase II prospective randomized placebo-con...
Other Medicine Technology:CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 2CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 3CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 4CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 5CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 6CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 7CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 8CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 9Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 5
...UHTS), Analyst GT delivers unsurpassed multimode a...sfer of assays into screening from assay developme...yst AD and HT, fluorescence intensity, fluorescenc...scence, absorbance, as well as providing seamless ...
...Analyst HT smoothes the transfer of assays into HT...y performance of Analyst AD, fluorescence intensit...cence, luminescence, absorbance. Optimized for se...uding those from Beckman Coulter, Zymark, CRS and ...
...lopment and basic research, including a simple ins...ime required to move assays into HTS. Specifically...ment laboratories, Analyst AD delivers unparallele..., Fluorescence Polarization, Time-Resolved Fluores...
...oplate based multi-detection reader which incorpor...orescence Polarization , Fluorescence Intensity ,...minescence (flash and glow) , Absorbance ,It i...dioactive labeled applications:, , Ca2+ Measuremen...
Medicine Products: